PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru. Patricia.garcia@upch.pe.\', \'Instituto de Salud Global (ISGlobal), Barcelona, Spain.\', \'School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.\', \'Tropical Medicine Institute Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.\', \'Hospital Nacional Cayetano Heredia, Lima, Peru.\', \'Facultad de Medicina, Universidad de Navarra, Pamplona, Spain.\', \'School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-021-05236-2
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33836826
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33836826>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33836826>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all